|
PBRM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.62219998229341E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.73480000054927E-07 |
| Normal-vs-Stage2 |
9.55059999999675E-05 |
| Normal-vs-Stage3 |
2.71279998464991E-09 |
| Normal-vs-Stage4 |
3.75709999778095E-08 |
| Stage1-vs-Stage2 |
8.214600E-01 |
| Stage1-vs-Stage3 |
7.527600E-02 |
| Stage1-vs-Stage4 |
6.446000E-02 |
| Stage2-vs-Stage3 |
3.308800E-01 |
| Stage2-vs-Stage4 |
2.618200E-01 |
| Stage3-vs-Stage4 |
7.535800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.93549998040288E-09 |
| Normal-vs-AfricanAmerican |
5.208200E-02 |
| Normal-vs-Asian |
1.17580000003059E-06 |
| Caucasian-vs-AfricanAmerican |
6.544400E-02 |
| Caucasian-vs-Asian |
6.276800E-01 |
| AfricanAmerican-vs-Asian |
5.107700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.90879997866256E-09 |
| Normal-vs-Female |
1.12189999956769E-07 |
| Male-vs-Female |
1.998220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.2657000000057E-06 |
| Normal-vs-Age(41-60Yrs) |
1.93579999807625E-08 |
| Normal-vs-Age(61-80Yrs) |
5.43010000297883E-08 |
| Normal-vs-Age(81-100Yrs) |
1.506060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.011800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.179000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.851000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.780000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.917400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.384800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.136800E-03 |
| Classical-VS-Follicular |
1.094570E-01 |
| Classical-VS-Other |
8.887800E-02 |
| Classical-VS-Normal |
7.75740000014125E-07 |
| Tall-VS-Follicular |
2.405200E-01 |
| Tall-VS-Other |
5.066600E-01 |
| Tall-VS-Normal |
3.49009999789374E-08 |
| Follicular-VS-Other |
3.279400E-01 |
| Follicular-VS-Normal |
1.74129999996886E-06 |
| Other-VS-Normal |
8.578400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1621000051143E-08 |
| Normal-vs-N1 |
4.8496999971448E-08 |
| N0-vs-N1 |
3.277200E-01 |
|
|
